CAR-T cell therapy for multiple myeloma has shown promising results, especially for those with advanced or hard-to-treat myeloma. Here are some key points:

- Remission Rates: In clinical trials, 2 out of 3 participants were in remission for at least one year
- Effectiveness: It has worked well for many people when other read more

CAR-T cell therapy for multiple myeloma has shown promising results, especially for those with advanced or hard-to-treat myeloma. Here are some key points:

- Remission Rates: In clinical trials, 2 out of 3 participants were in remission for at least one year.
- Effectiveness: It has worked well for many people when other treatments have failed.
- Long-term Efficacy: It's too soon to determine the long-term effectiveness.
- Side Effects: Most side effects are mild, but serious side effects can occur.

Always discuss the risks and benefits with your doctor.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Gene-Based Therapy May Thwart a Tough Blood Cancer | MyMyelomaTeam